Longitudinal Follow-up of High Viscosity Glassionomer IonoStar Plus Versus a Composite Bulk X-tra-Fil Combined With Futurabond U (Splith Mouth Study): Reunion Island, Circus of Mafate (CVB)

June 22, 2018 updated by: University Hospital, Montpellier
The main objective is the longitudinal follow-up and comparison of the maintenance of the dental filling materials up to 24 months using the HVGIC IonoStar Plus versus Bulk X-Tra -Fil composite (Futurabond U adhesive system). 150 patients will be recruited in the Mafate dental health center. Patients with minimum 2 carious lesions (or multiple of 2, maximum 6) class I or II moderate not including the cusps, and touching the outside part of the middle of dentin. Assignment period will be 4 years: Inclusion period 18 months with 2 years following (6-month, 1 year and 2 years checking) and 3 months for statistical analysis and publications process Estimation of the parameters associated with a failure of the restoration at 24 months will follow the FDI scores. The Secondary objectives are to evaluate the caries risk of isolated population thanks to Cambra application and estimate the concordance of the judgment of maintaining the restoration between the expert in-situ and experts based on the images remotely.

Study Overview

Status

Unknown

Conditions

Study Type

Interventional

Enrollment (Anticipated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34090
        • Recruiting
        • CHU Montpellier
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient with 2 carious lesions (or multiple of 2) class I or II moderate not including the cusps, and touching the outside part of the middle of dentin
  • Asymptomatic tooth or with a reversible pulp syndrome tooth
  • Measured by pulp test (if not possible should not prevent the inclusion)
  • Patient consultant in investigative testing center
  • Patient of 18 to 70 years old
  • Patient able to support care
  • Patient able to understand care (no language barrier)
  • Collect the informed consent signed after a period of reflection
  • Be affiliated to a French social security scheme or recipient of such a regime
  • Tooth with criteria for pulp vitality tests of pulp sensibility

Exclusion Criteria:

  • Patient under guardianship
  • Pregnant or breastfeeding
  • Patient at risk for infectious endocarditis
  • Patient with severe periodontal disease (Pocket depth ≥ 5mm and/or mobility IV)
  • Patient with an allergy to one of the materials used in the study
  • Patient with an allergy to local anesthesia
  • Patient with risks of infectious endocarditis
  • Non-cooperative patient
  • Participate in another ongoing biomedical research

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Bulk fil composite
Treatment by Bulk fil composite after randomization of the tooth
Treatment by High viscosity glass ionomer after randomization of the tooth
Active Comparator: High viscosity glass ionomer
Treatment by Bulk fil composite after randomization of the tooth
Treatment by High viscosity glass ionomer after randomization of the tooth

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of the International Dental Federation Score
Time Frame: Change from Baseline Score FDI at 2 years
Score are numbered from 1 to 5 in ascending order of severity for aesthetic criteria (5 items), functional criteria (9 items) and biological criteria (6 items). The score will be used by the practionner making the restoration and by the remote expert to check the results and validate tele-dentistry evaluation.
Change from Baseline Score FDI at 2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Validation of the caries risk assememt.
Time Frame: Change from Baseline caries risk assement at 2 years
Caries assessment is based on CAMBRA application https://course.mycambra.com/ (Caries Management By Risk Assessment) score giving 3 levels of caries assessment : Low - Moderate - High.
Change from Baseline caries risk assement at 2 years
The carious presence according to the ICDAS / ICCMS criteria using the Soprolife® camera
Time Frame: At each follow-up visit (T0, T6 months, T1year and T2years)
ICCMS: caries prevalence measurement based on the ICDAS classification
At each follow-up visit (T0, T6 months, T1year and T2years)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

June 30, 2018

Primary Completion (Anticipated)

December 1, 2019

Study Completion (Anticipated)

June 1, 2022

Study Registration Dates

First Submitted

May 14, 2018

First Submitted That Met QC Criteria

June 22, 2018

First Posted (Actual)

June 26, 2018

Study Record Updates

Last Update Posted (Actual)

June 26, 2018

Last Update Submitted That Met QC Criteria

June 22, 2018

Last Verified

June 1, 2018

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caries

Clinical Trials on Caries treatment

3
Subscribe